Neuroscience News -
27 Aug 2018 18:39
Researchers successfully used a synthetic compound to stimulate a receptor pathway to promote remyelination in the brain. The technique may have significant beneficial implications for treating multiple sclerosis, researchers say.
Share this Article
Comment on this Article
Please to comment